"Many
gene transfer consent forms misleading: study." Reuters Health,
2002.
"Special Series: Assessing Risks/Benefits. Assessing a clinical trial's risks and benefits requires closer IRB attention." IRB Advisor, vol. 2, no. 10 (October, 2002): 109-112.
"A risk-benefit matrix should ask the right questions." IRB Advisor, vol. 2, no. 10 (October, 2002): 113-114.
"Experts to study informed consent in national gene transfer research." David Williamson, UNC-CH News Services, (Jan. 10, 1999).